{"color":"#336699","name":"Dr Sarah Sand...","data":{"first_name":"Sarah","title":"Dr","dw_individual_id":"5046546","middle_name":"","last_name":"Sandaradura","source_individual_id":"5046546","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sarah Sandaradura"},"children":[{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2015,"keywords":["myopathy","neuromuscular diseases","clinical genetics","molecular genetics","genetic disorders"],"nhmrc_grant_id":1075451,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurogenetics","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Dr Sarah Sandaradura","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1075451","simplified_title":"Nemaline myopathy: a clinical and genetic review","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"57247.67","source_system":"Nemaline myopathy is a neuromuscular condition characterised by muscle weakness, low muscle tone and the finding of nemaline bodies or rods on muscle biopsy. This study encompasses a natural history study of nemaline myopathy, genetic diagnosis and gene discovery using new methods of genetic testing, characterisation of a new disease gene for this condition, and reviewing patient experience with tyrosine, a medication commonly used in patients with nemaline myopathy."},"children":[{"color":"#0066FF","name":"University of...","data":{"source":"NHMRC","name":"University of Sydney","state":"NSW","nla":"http://nla.gov.au/nla.party-593941","type":"University","node_source":"NHMRC","node_type":"Institution"},"class":"Institution","self":"http://localhost:7474/db/data/node/13","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76081","size":1}],"class":"Researcher","self":"http://localhost:7474/db/data/node/76255","size":1}